Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0009952 (
febrile convulsions
)
1,215
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A pharmacokinetic study of sodium valproate (
DPA
) was undertaken in children treated with this drug after a febrile convulsion. In infants, after a single oral dose of 20 mg/kg body weight in the first morning meal, plasma kinetic data were as follows: T max 2.4 hr +/- 1.1; total
DPA
maximum plasma concentration: 94 micrograms/ml +/- 28; T 1/2: 12.4 hr +/- 4.9; the distribution volume was 0.25 l/kg +2- 0.07 and plasma clearance was 0.014 l/kg/hr +2- 0.004. Control of prolonged treatment showed that the measured plasma concentrations were not correlated with the daily dosage. Furthermore, when
febrile convulsions
are concerned, one should carefully weight the recently reported hepatic toxicity of
DPA
, against the usually good prognosis of
febrile convulsions
.
...
PMID:[Pharmacokinetic elements of sodium valproate. Use in febrile convulsions in children]. 640 54